By Paul Perreault
March 7, 2017
One of the things I like to remind our people to do is remember where we came from. In reflecting on my recent interview with Medical Marketing & Media (MM&M) magazine, in which I talked about CSL Limited’s unique beginning as a government agency, it strikes me that we really are unlike other biotechs.
Founded by the Australian government in 1916, CSL was born to serve people. It wasn’t until 1994 that we were privatized. CSL was established to ensure a continuous supply of medicines to Australians would not be disrupted by World War I. As I mentioned in my interview, we started with a mindset that reflected our government heritage – we’re always scrapping.
Paradigm shift from doing to and for patients, to a more engaging environment of doing with patients
By Anthony Farina
Nearly every healthcare organization talks about putting patients first, but what does patient centricity really mean? CSL’s CEO and Managing Director Paul Perreault, who recently addressed the subject of patient-centric leadership at the 14th eyeforpharma Philadelphia Summit, says it’s about innately understanding the big picture, in other words the patient’s whole story, not just his or her medical condition.
“It requires understanding patients’ specific needs, what they’re going through, and the types of stresses these conditions place on them and their families,” Perreault says. “It also means providing not only treatment but resources and emotional support designed to improve outcomes and enhance quality of life and wellbeing.”